Nathan Price
corporateWebsite
Fund rating
0.0 / 35
0 published reviews
No per-dimension scores yet.
Published reviews
About
Evidence [2] identifies Nathan Price as Co-Director of the Center for Human Healthspan, Chief Scientific Officer of Thorne, and former CEO of Onegevity, an AI health intelligence company. That combination of aging science, AI/omics, and commercial health-tech experience is directly relevant to OpenDrugs' evidence, comparison, and translational positioning.